Literature DB >> 24330092

Mechanisms of selective laser trabeculoplasty: a review.

Dov B Kagan1, Nathan S Gorfinkel, Cindy M L Hutnik.   

Abstract

Selective laser trabeculoplasty is a safe and effective treatment for glaucoma, with greater cost effectiveness than its pharmacological and surgical alternatives. Nevertheless, although the basic science literature on selective laser trabeculoplasty continues to grow, there remains uncertainty over the mechanism by which laser trabeculoplasty reduces intraocular pressure. To address this uncertainty, the evidence behind several potential biological and mechanical mechanisms of selective laser trabeculoplasty were reviewed. In particular, cytokine secretion, matrix metalloproteinase induction, increased cell division, repopulation of burn sites and macrophage recruitment were discussed. Refining our understanding of these mechanisms is essential both to understanding the pathophysiology of ocular hypertension and developing improved therapies to treat the condition.
© 2013 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  ALT; SLT; argon laser trabeculoplasty; mechanism; selective laser trabeculoplasty

Mesh:

Year:  2014        PMID: 24330092     DOI: 10.1111/ceo.12281

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  25 in total

1.  Impact of laser pulse duration on the reduction of intraocular pressure during selective laser trabeculoplasty.

Authors:  Spela Stunf Pukl; Brigita Drnovšek-Olup
Journal:  Int Ophthalmol       Date:  2016-12-31       Impact factor: 2.031

2.  A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand.

Authors:  Kelvin Ngan; Ewan Fraser; Sophie Buller; Alex Buller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-21       Impact factor: 3.117

Review 3.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

4.  Selective laser trabeculoplasty in patients with pseudoexfoliative glaucoma vs primary open angle glaucoma: a one-year comparative study.

Authors:  Arezoo Miraftabi; Naveed Nilforushan; Nariman Nassiri; Kouros Nouri-Mahdavi
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

5.  Efficacy of selective laser trabeculoplasty in primary angle closure disease.

Authors:  Srishti Raj; Basavraj Tigari; T T Faisal; Natasha Gautam; Sushmita Kaushik; Parul Ichhpujani; Surinder S Pandav; Jagat Ram
Journal:  Eye (Lond)       Date:  2018-07-09       Impact factor: 3.775

6.  Intraocular Pressure Reduction by Femtosecond Laser Created Trabecular Channels in Perfused Human Anterior Segments.

Authors:  Eric Mikula; Guy Holland; Samantha Bradford; Reza Khazaeinezhad; Hadi Srass; Carlos Suarez; James V Jester; Tibor Juhasz
Journal:  Transl Vis Sci Technol       Date:  2021-08-02       Impact factor: 3.048

Review 7.  Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.

Authors:  Raul E Ruiz-Lozano; Jimena Alamillo-Velazquez; Gustavo Ortiz-Morales; Lucas A Garza-Garza; Manuel E Quiroga-Garza; Carlos Alvarez-Guzman; Alejandro Rodriguez-Garcia
Journal:  Int Ophthalmol       Date:  2022-08-13       Impact factor: 2.029

8.  CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma.

Authors:  Milica A Margeta; Eleonora M Lad; Alan D Proia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-02       Impact factor: 3.117

9.  Experimental study of trabecular tissue repair for corneal defect in rabbits.

Authors:  Xia Li; Yun Xiao; Xiao-Wei Gao; Yi Liu; Dai-Kun Lei
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

10.  Towards Automatically Controlled Dosing for Selective Laser Trabeculoplasty.

Authors:  Katharina Bliedtner; Eric Seifert; Ralf Brinkmann
Journal:  Transl Vis Sci Technol       Date:  2019-12-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.